Vanderbilt Hemostasis Treatment Clinic — Nashville, Tennessee

Vanderbilt Hemostasis Treatment Clinic is a clinical research site located in Nashville, Tennessee, United States 37212.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Hemostasis Treatment Clinic has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Haemophilia A and B With and Without Inhibitors, Hemophilia A.

Sponsors: Novo Nordisk A/S, Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Hemostasis Treatment Clinic?

Vanderbilt Hemostasis Treatment Clinic has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Hemostasis Treatment Clinic conducted?

Vanderbilt Hemostasis Treatment Clinic has 2 clinical trials on record, with 1 currently active. Their work covers Haemophilia A and B With and Without Inhibitors, Hemophilia A.

Is Vanderbilt Hemostasis Treatment Clinic accredited by Crixeo Health?

Vanderbilt Hemostasis Treatment Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Hemostasis Treatment Clinic?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.